The Potential of Plant-Derived Extracts and Compounds to Augment Anticancer Effects of Chemotherapeutic Drugs

References

• World Health Organization. WHO | NCD mortality and morbidity 2020.
   Google Scholar
• Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer J Clin. 2021;71:209–49.
   PubMed Web of Science ®Google Scholar
• Shah SC, Kayamba V, Peek RM, Jr, Heimburger D. Cancer control in low- and middle-income countries: is it time to consider screening? J Glob Oncol. 2019;5:1–8. doi:10.1200/JGO.18.00200
   Web of Science ®Google Scholar
• Wang X, Zhang H, Chen X. Drug resistance and combating drug resistance in cancer. Cancer Drug Resist. 2019;2:141–60. doi:10.20517/cdr.2019.10
   PubMedGoogle Scholar
• Camidge DR, Pao W, Sequist LV. Acquired resistance to TKIs in solid tumours: learning from lung cancer. Nat Rev Clin Oncol. 2014;11(8):473–81. doi:10.1038/nrclinonc.2014.104
   PubMed Web of Science ®Google Scholar
• Chun SY, Kwon YS, Nam KS, Kim S. Lapatinib enhances the cytotoxic effects of doxorubicin in MCF-7 tumorspheres by inhibiting the drug efflux function of ABC transporters. Biomed Pharmacother. 2015;72:37–43. doi:10.1016/j.biopha.2015.03.009
   PubMed Web of Science ®Google Scholar
• Jacqueroux E, Mercier C, Margelidon-Cozzolino V, Hodin S, Bertoletti L, Delavenne X. In vitro assessment of P-gp and BCRP transporter-mediated drug-drug interactions of riociguat with direct oral anticoagulants. Fundam Clin Pharmacol. 2020;34(1):109–19. doi:10.1111/fcp.12504
   PubMed Web of Science ®Google Scholar
• Orlando UD, Castillo AF, Medrano MAR, Solano AR, Maloberti PM, Podesta EJ. Acyl-CoA synthetase-4 is implicated in drug resistance in breast cancer cell lines involving the regulation of energy-dependent transporter expression. Biochem Pharmacol. 2019;159:52–63. doi:10.1016/j.bcp.2018.11.005
   PubMed Web of Science ®Google Scholar
• Yang C, Hou A, Yu C, Dai L, Wang W, Zhang K, Shao H, Ma J, Xu W. Kanglaite reverses multidrug resistance of HCC by inducing apoptosis and cell cycle arrest via PI3K/AKT pathway. Onco Targets Ther. 2018;11:983–96. doi:10.2147/OTT.S153814
   PubMed Web of Science ®Google Scholar
• Rastgoo N, Abdi J, Hou J, Chang H. Role of epigenetics-microRNA axis in drug resistance of multiple myeloma. J Hematol Oncol. 2017;10(1):121. doi:10.1186/s13045-017-0492-1
   PubMed Web of Science ®Google Scholar
• Chen H, Wang X, Gou S. A cisplatin-based platinum(IV) prodrug containing a glutathione s-transferase inhibitor to reverse cisplatin-resistance in non-small cell lung cancer. J Inorg Biochem. 2019;193:133–42. doi:10.1016/j.jinorgbio.2019.01.014
   PubMed Web of Science ®Google Scholar
• de Klerk DJ, Honeywell RJ, Jansen G, Peters GJ. Transporter and lysosomal mediated (multi)drug resistance to tyrosine kinase inhibitors and potential strategies to overcome resistance. Cancers (Basel). 2018;10(12):503. doi:10.3390/cancers10120
   PubMed Web of Science ®Google Scholar
• Yeldag G, Rice A, Del Rio HA. Chemoresistance and the self-maintaining tumor microenvironment. Cancers (Basel). 2018;10(12):471. doi:10.3390/cancers10120471
   PubMed Web of Science ®Google Scholar
• Liang F, Ren C, Wang J, Wang S, Yang L, Han X, Chen Y, Tong G, Yang G. The crosstalk between STAT3 and p53/RAS signaling controls cancer cell metastasis and cisplatin resistance via the Slug/MAPK/PI3K/AKT-mediated regulation of EMT and autophagy. Oncogenesis. 2019;8(10):59. doi:10.1038/s41389-019-0165-8
   PubMed Web of Science ®Google Scholar
• Duan S, Li J, Tian J, Yin H, Zhai Q, Wu Y, Yao S, Zhang L. Crosstalk between let-7a-5p and BCL-xL in the initiation of toxic autophagy in lung cancer. Mol Ther Oncolytics. 2019;15:69–78. doi:10.1016/j.omto.2019.08.010
   PubMed Web of Science ®Google Scholar
• Zhang L, Tian S, Pei M, Zhao M, Wang L, Jiang Y, Yang T, Zhao J, Song L, Yang X, et al. Crosstalk between histone modification and DNA methylation orchestrates the epigenetic regulation of the costimulatory factors, Tim‑3 and galectin‑9, in cervical cancer. Oncol Rep. 2019;42(6):2655–69. doi:10.3892/or.2019.7388
   PubMed Web of Science ®Google Scholar
• Laconi E, Marongiu F, DeGregori J. Cancer as a disease of old age: Changing mutational and microenvironmental landscapes. Br J Cancer. 2020;122(7):943–52. doi:10.1038/s41416-019-0721-1
   PubMed Web of Science ®Google Scholar
• Baxevanos P, Mountzios G. Novel chemotherapy regimens for advanced lung cancer: have we reached a plateau? Ann Transl Med. 2018;6(8):139– doi:10.21037/atm.2018.04.04
   PubMed Web of Science ®Google Scholar
• Kikuchi H, Yuan B, Hu X, Okazaki M. Chemopreventive and anticancer activity of flavonoids and its possibility for clinical use by combining with conventional chemotherapeutic agents. Am J Cancer Res. 2019;9(8):1517–35.
   PubMed Web of Science ®Google Scholar
• Sardar AA, Perveen A, Khan ZU, Farid S, Khan I. Phytochemical screening, GC-MS analysis and in vitro antioxidant activity of pollen of Centella asiatica (Linn) urban a traditional medicinal plant. Pak J Pharm Sci. 2017;30:2239–45.
   PubMed Web of Science ®Google Scholar
• Xiang Y, Guo Z, Zhu P, Chen J, Huang Y. Traditional Chinese medicine as a cancer treatment: modern perspectives of ancient but advanced science. Cancer Med. 2019;8(5):1958–75. doi:10.1002/cam4.2108
   PubMed Web of Science ®Google Scholar
• Ahmed S, Khan H, Mirzaei H, Hasan MM, Eddouks M, et al. Herbal drug interaction: mechanistic details through the pharmacokinetic portfolio. CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS & Neurological Disorders). 2020.
   Google Scholar
• Alam M, Ali S, Ashraf GM, Bilgrami AL, Yadav DK, Hassan MI. Epigallocatechin 3-gallate: from green tea to cancer therapeutics. Food Chem. 2022;379:132135. doi:10.1016/j.foodchem.2022.132135
   PubMed Web of Science ®Google Scholar
• Batra H, Pawar S, Bahl D. Curcumin in combination with anti-cancer drugs: a nanomedicine review. Pharmacol Res. 2019;139:91–105. doi:10.1016/j.phrs.2018.11.005
   PubMed Web of Science ®Google Scholar
• Kim J, Kim H-Y, Hong S, Shin S, Kim YA, Kim NS, Bang O-S. A new herbal formula BP10A exerted an antitumor effect and enhanced anticancer effect of irinotecan and oxaliplatin in the colon cancer PDTX model. Biomed Pharmacother. 2019;116:108987. doi:10.1016/j.biopha.2019.108987
   PubMed Web of Science ®Google Scholar
• Opattova A, Horak J, Vodenkova S, Kostovcikova K, Cumova A, Macinga P, Galanova N, Rejhova A, Vodickova L, Kozics K, et al. Ganoderma Lucidum induces oxidative DNA damage and enhances the effect of 5-Fluorouracil in colorectal cancer in vitro and in vivo. Mutat Res Genet Toxicol Environ Mutagen. 2019;845:403065. doi:10.1016/j.mrgentox.2019.06.001
   PubMed Web of Science ®Google Scholar
• Huang C-Y, Chen JY-F, Wu J-E, Pu Y-S, Liu G-Y, Pan M-H, Huang Y-T, Huang A-M, Hwang C-C, Chung S-J, et al. Ling-Zhi polysaccharides potentiate cytotoxic effects of anticancer drugs against drug-resistant urothelial carcinoma cells. J Agric Food Chem. 2010;58(15):8798–805. doi:10.1021/jf1020158
   PubMed Web of Science ®Google Scholar
• Su J, Zhang F, Li X, Liu Z. Osthole promotes the suppressive effects of cisplatin on NRF2 expression to prevent drug-resistant cervical cancer progression. Biochem Biophys Res Commun. 2019;514(2):510–7. doi:10.1016/j.bbrc.2019.04.021
   PubMed Web of Science ®Google Scholar
• Ye J, Sun D, Yu Y, Yu J. Osthole resensitizes CD133+ hepatocellular carcinoma cells to cisplatin treatment via PTEN/AKT pathway. Aging (Albany NY). 2020;12(14):14406–17. doi:10.18632/aging.103484
   PubMedGoogle Scholar
• Piska K, Koczurkiewicz P, Wnuk D, Karnas E, Bucki A, Wójcik-Pszczoła K, Jamrozik M, Michalik M, Kołaczkowski M, Pękala E, et al. Synergistic anticancer activity of doxorubicin and piperlongumine on DU-145 prostate cancer cells – The involvement of carbonyl reductase 1 inhibition. Chem Biol Interact. 2019;300:40–8. doi:10.1016/j.cbi.2019.01.003
   PubMed Web of Science ®Google Scholar
• Fatfat M, Fakhoury I, Habli Z, Mismar R, Gali-Muhtasib H. Thymoquinone enhances the anticancer activity of doxorubicin against adult T-cell leukemia in vitro and in vivo through ROS-dependent mechanisms. Life Sci. 2019;232:116628. doi:10.1016/j.lfs.2019.116628
   PubMed Web of Science ®Google Scholar
• Tayeh Z, Ofir R. Asteriscus graveolens extract in combination with cisplatin/etoposide/doxorubicin suppresses lymphoma cell growth through induction of caspase-3 dependent apoptosis. IJMS. 2018;19(8):2219. doi:10.3390/ijms19082219
   Web of Science ®Google Scholar
• Jung SY, Kim C, Kim W-S, Lee S-G, Lee J-H, Shim BS, Kim S-H, Ahn KS, Ahn KS. Korean Red Ginseng extract enhances the anticancer effects of Imatinib Mesylate through abrogation p38 and STAT5 activation in KBM-5 cells. Phytother Res. 2015;29(7):1062–72. doi:10.1002/ptr.5347
   PubMed Web of Science ®Google Scholar
• Kim C, Lee JH, Baek SH, Ko J-H, Nam D, Ahn KS. Korean Red Ginseng extract enhances the anticancer effects of Sorafenib through abrogation of CREB and c-Jun activation in renal cell carcinoma. Phytother Res. 2017;31(7):1078–89. doi:10.1002/ptr.5829
   PubMed Web of Science ®Google Scholar
• Lu M, Fei Z, Zhang G. Synergistic anticancer activity of 20(S)-Ginsenoside Rg3 and Sorafenib in hepatocellular carcinoma by modulating PTEN/Akt signaling pathway. Biomed Pharmacother. 2018;97:1282–8. doi:10.1016/j.biopha.2017.11.006
   PubMed Web of Science ®Google Scholar
• Chen Z, Wei X, Shen L, Zhu H, Zheng X. 20(S)-ginsenoside-Rg3 reverses temozolomide resistance and restrains epithelial-mesenchymal transition progression in glioblastoma. Cancer Sci. 2019;110(1):389–400. doi:10.1111/cas.13881
   PubMed Web of Science ®Google Scholar
• Yuan YG, Gurunathan S. Combination of graphene oxide-silver nanoparticle nanocomposites and cisplatin enhances apoptosis and autophagy in human cervical cancer cells. Int J Nanomed. 2017;12:6537–58. doi:10.2147/IJN.S125281
   PubMed Web of Science ®Google Scholar
• Fukuda M, Sakashita H, Hayashi H, Shiono J, Miyake G, Komine Y, Taira F, Sakashita H. Synergism between α-mangostin and TRAIL induces apoptosis in squamous cell carcinoma of the oral cavity through the mitochondrial pathway. Oncol Rep. 2017;38(6):3439–46. doi:10.3892/or.2017.6030
   PubMed Web of Science ®Google Scholar
• Kim M, Chin Y-W, Lee EJ. α, γ-Mangostins induce autophagy and show synergistic effect with gemcitabine in pancreatic cancer cell lines. Biomol Ther (Seoul). 2017;25(6):609–17. doi:10.4062/biomolther.2017.074
   PubMed Web of Science ®Google Scholar
• Kleinsimon S, Kauczor G, Jaeger S, Eggert A, Seifert G, Delebinski C. ViscumTT induces apoptosis and alters IAP expression in osteosarcoma in vitro and has synergistic action when combined with different chemotherapeutic drugs. BMC Complement Altern Med. 2017;17(1):26. doi:10.1186/s12906-016-1545-7
   PubMed Web of Science ®Google Scholar
• Ramachandran C, Quirin KW, Escalon EA, Lollett IV, Melnick SJ. Therapeutic effect of supercritical CO2 extracts of curcuma species with cancer drugs in rhabdomyosarcoma cell lines. Phytother Res. 2015;29(8):1152–60. doi:10.1002/ptr.5360
   PubMed Web of Science ®Google Scholar
• Sun M, Zhang N, Wang X, Cai C, Cun J, Li Y, Lv S, Yang Q. Nitidine chloride induces apoptosis, cell cycle arrest, and synergistic cytotoxicity with doxorubicin in breast cancer cells. Tumour Biol. 2014;35(10):10201–12. doi:10.1007/s13277-014-2327-9
   PubMedGoogle Scholar
• Yaacob NS, Kamal NN, Norazmi MN. Synergistic anticancer effects of a bioactive subfraction of Strobilanthes crispus and tamoxifen on MCF-7 and MDA-MB-231 human breast cancer cell lines. BMC Complement Altern Med. 2014;14:252. doi:10.1186/1472-6882-14-252
   PubMed Web of Science ®Google Scholar
• Samy RP, Rajendran P, Li F, Anandi NM, Stiles BG, Ignacimuthu S, Sethi G, Chow VTK. Identification of a novel Calotropis procera protein that can suppress tumor growth in breast cancer through the suppression of NF-κB pathway. PloS One. 2012;7(12):e48514. doi:10.1371/journal.pone.0048514
   PubMed Web of Science ®Google Scholar
• Zhao X, Chen Q, Li Y, Tang H, Liu W, Yang X. Doxorubicin and curcumin co-delivery by lipid nanoparticles for enhanced treatment of diethylnitrosamine-induced hepatocellular carcinoma in mice. Eur J Pharm Biopharm. 2015;93:27–36. doi:10.1016/j.ejpb.2015.03.003
   PubMed Web of Science ®Google Scholar
• Sahu BP, Hazarika H, Bharadwaj R, Loying P, Baishya R, Dash S, Das MK. Curcumin-docetaxel co-loaded nanosuspension for enhanced anti-breast cancer activity. Expert Opin Drug Deliv. 2016;13(8):1065–74. doi:10.1080/17425247.2016.1182486
   PubMed Web of Science ®Google Scholar
• Sen K, Banerjee S, Mandal M. Dual drug loaded liposome bearing apigenin and 5-Fluorouracil for synergistic therapeutic efficacy in colorectal cancer. Colloids Surf B Biointerfaces. 2019;180:9–22. doi:10.1016/j.colsurfb.2019.04.035
   PubMed Web of Science ®Google Scholar
• Yang Z, Liu Y, Liao J, Gong C, Sun C, Zhou X, Wei X, Zhang T, Gao Q, Ma D, et al. Quercetin induces endoplasmic reticulum stress to enhance cDDP cytotoxicity in ovarian cancer: involvement of STAT3 signaling. FEBS J. 2015;282(6):1111–25. doi:10.1111/febs.13206
   PubMed Web of Science ®Google Scholar
• Jeon YW, Suh YJ. Synergistic apoptotic effect of celecoxib and luteolin on breast cancer cells. Oncol Rep. 2013;29(2):819–25. doi:10.3892/or.2012.2158
   PubMed Web of Science ®Google Scholar
• Jeon YW, Ahn YE, Chung WS, Choi HJ, Suh YJ. Synergistic effect between celecoxib and luteolin is dependent on estrogen receptor in human breast cancer cells. Tumour Biol. 2015;36(8):6349–59. doi:10.1007/s13277-015-3322-5
   PubMedGoogle Scholar
• Tan K-T, Li S, Li YR, Cheng S-L, Lin S-H, Tung Y-T. Synergistic anticancer effect of a combination of Paclitaxel and 5-demethylnobiletin against lung cancer cell line in vitro and in vivo. Appl Biochem Biotechnol. 2019;187(4):1328–43. doi:10.1007/s12010-018-2869-1
   PubMed Web of Science ®Google Scholar
• Xu H, Yang T, Liu X, Tian Y, Chen X, Yuan R, Su S, Lin X, Du G. Luteolin synergizes the antitumor effects of 5-fluorouracil against human hepatocellular carcinoma cells through apoptosis induction and metabolism. Life Sci. 2016;144:138–47. doi:10.1016/j.lfs.2015.12.002
   PubMed Web of Science ®Google Scholar
• Ren L-Q, Li Q, Zhang Y. Luteolin suppresses the proliferation of gastric cancer cells and acts in synergy with oxaliplatin. Biomed Res Int. 2020;2020:9396512. doi:10.1155/2020/9396512
   PubMed Web of Science ®Google Scholar
• Kong L, Wang X, Zhang K, Yuan W, Yang Q, Fan J, Wang P, Liu Q. Gypenosides synergistically enhances the anti-tumor effect of 5-fluorouracil on colorectal cancer in vitro and in vivo: a role for oxidative stress-mediated DNA damage and p53 activation. PloS One. 2015;10(9):e0137888. doi:10.1371/journal.pone.0137888
   PubMed Web of Science ®Google Scholar
• Lu G, Xiao H, You H, Lin Y, Jin H, Snagaski B, Yang CS. Synergistic inhibition of lung tumorigenesis by a combination of green tea polyphenols and atorvastatin. Clin Cancer Res. 2008;14(15):4981–8. doi:10.1158/1078-0432.CCR-07-1860
   PubMed Web of Science ®Google Scholar
• Tyagi T, Treas JN, Mahalingaiah PK, Singh KP. Potentiation of growth inhibition and epigenetic modulation by combination of green tea polyphenol and 5-aza-2’-deoxycytidine in human breast cancer cells. Breast Cancer Res Treat. 2015;149(3):655–68. doi:10.1007/s10549-015-3295-5
   PubMed Web of Science ®Google Scholar
• Wang R, Huang J, Chen J, Yang M, Wang H, Qiao H, Chen Z, Hu L, Di L, Li J, et al. Enhanced anti-colon cancer efficacy of 5-fluorouracil by epigallocatechin-3- gallate co-loaded in wheat germ agglutinin-conjugated nanoparticles. Nanomedicine. 2019;21:102068. doi:10.1016/j.nano.2019.102068
   PubMed Web of Science ®Google Scholar
• Toden S, Tran H-M, Tovar-Camargo OA, Okugawa Y, Goel A. Epigallocatechin-3-gallate targets cancer stem-like cells and enhances 5-fluorouracil chemosensitivity in colorectal cancer. Oncotarget. 2016;7(13):16158–71. doi:10.18632/oncotarget.7567
   PubMedGoogle Scholar
• Tang H, Zeng L, Wang J, Zhang X, Ruan Q, Wang J, Cui S, Yang D. Reversal of 5-fluorouracil resistance by EGCG is mediate by inactivation of TFAP2A/VEGF signaling pathway and down-regulation of MDR-1 and P-gp expression in gastric cancer. Oncotarget. 2017;8(47):82842–53. doi:10.18632/oncotarget.20666
   PubMedGoogle Scholar
• Berkovich L, Earon G, Ron I, Rimmon A, Vexler A, Lev-Ari S. Moringa Oleifera aqueous leaf extract down-regulates nuclear factor-kappaB and increases cytotoxic effect of chemotherapy in pancreatic cancer cells. BMC Complement Altern Med. 2013;13:212. doi:10.1186/1472-6882-13-212
   PubMed Web of Science ®Google Scholar
• In LLA, Arshad NM, Ibrahim H, Azmi MN, Awang K, Nagoor NH. 1’-Acetoxychavicol acetate inhibits growth of human oral carcinoma xenograft in mice and potentiates cisplatin effect via proinflammatory microenvironment alterations. BMC Complement Altern Med. 2012;12:179. doi:10.1186/1472-6882-12-179
   PubMed Web of Science ®Google Scholar
• Guo S, Zhang Y, Wu Z, Zhang L, He D, Li X, Wang Z. Synergistic combination therapy of lung cancer: Cetuximab functionalized nanostructured lipid carriers for the co-delivery of paclitaxel and 5-Demethylnobiletin. Biomed Pharmacother. 2019;118:109225. doi:10.1016/j.biopha.2019.109225
   PubMed Web of Science ®Google Scholar
• Maryam A, Mehmood T, Zhang H, Li Y, Khan M, Ma T. Alantolactone induces apoptosis, promotes STAT3 glutathionylation and enhances chemosensitivity of A549 lung adenocarcinoma cells to doxorubicin via oxidative stress. Sci Rep. 2017;7(1):1–18. doi:10.1038/s41598-017-06535-y
   PubMed Web of Science ®Google Scholar
• Wang J, Zhang Y, Liu X, Wang J, Li B, Liu Y, Wang J. Alantolactone enhances gemcitabine sensitivity of lung cancer cells through the reactive oxygen species-mediated endoplasmic reticulum stress and Akt/GSK3β pathway. Int J Mol Med. 2019;44(3):1026–38. doi:10.3892/ijmm.2019.4268
   PubMed Web of Science ®Google Scholar
• Bao S, Zheng H, Ye J, Huang H, Zhou B, Yao Q, Lin G, Zhang H, Kou L, Chen R, et al. Dual targeting EGFR and STAT3 with Erlotinib and Alantolactone co-loaded PLGA nanoparticles for pancreatic cancer treatment. Front Pharmacol. 2021;12:625084. doi:10.3389/fphar.2021.625084
   PubMed Web of Science ®Google Scholar
• Jen SH, Wei MPS, Yin ACY. The Combinatory effects of Glabridin and Tamoxifen on Ishikawa and MCF-7 cell lines. Nat Prod Commun. 2015;10(9):1934578X1501000922. doi:10.1177/1934578X1501000922
   Web of Science ®Google Scholar
• Cai Y, Zhao B, Liang Q, Zhang Y, Cai J, Li G. The selective effect of glycyrrhizin and glycyrrhetinic acid on topoisomerase IIα and apoptosis in combination with etoposide on triple negative breast cancer MDA-MB-231 cells. Eur J Pharmacol. 2017;809:87–97. doi:10.1016/j.ejphar.2017.05.026
   PubMed Web of Science ®Google Scholar
• Wang Z, Wang N, Liu P, Chen Q, Situ H, Xie T, Zhang J, Peng C, Lin Y, Chen J, et al. MicroRNA-25 regulates chemoresistance-associated autophagy in breast cancer cells, a process modulated by the natural autophagy inducer isoliquiritigenin. Oncotarget. 2014;5(16):7013–26. doi:10.18632/oncotarget.2192
   PubMedGoogle Scholar
• Wang N, Wang Z, Peng C, You J, Shen J, Han S, Chen J. Dietary compound isoliquiritigenin targets GRP78 to chemosensitize breast cancer stem cells via β-catenin/ABCG2 signaling. Carcinogenesis. 2014;35(11):2544–54. doi:10.1093/carcin/bgu187
   PubMed Web of Science ®Google Scholar
• Lin L-C, Wu C-H, Shieh T-M, Chen H-Y, Huang T-C, Hsia S-M. The licorice dietary component isoliquiritigenin chemosensitizes human uterine sarcoma cells to doxorubicin and inhibits cell growth by inducing apoptosis and autophagy via inhibition of m-TOR signaling. J Funct Foods. 2017;33:332–44. doi:10.1016/j.jff.2017.03.061
   Web of Science ®Google Scholar
• Lee J, Lee YJ, Kim J, Bang OS. Pyranocoumarins from root extracts of Peucedanum praeruptorum Dunn with multidrug resistance reversal and anti-inflammatory activities. Molecules. 2015;20(12):20967–78. doi:10.3390/molecules201219738
   PubMed Web of Science ®Google Scholar
• Park JS, Lim CJ, Bang OS, Kim NS. Ethanolic extract of Descurainia sophia seeds sensitizes A549 human lung cancer cells to TRAIL cytotoxicity by upregulating death receptors. BMC Complement Altern Med. 2016;16:115. doi:10.1186/s12906-016-1094-0
   PubMed Web of Science ®Google Scholar
• Lee YJ, Kim NS, Kim H, Yi J-M, Oh S-M, Bang O-S, Lee J. Cytotoxic and anti-inflammatory constituents from the seeds of Descurainia sophia. Arch Pharm Res. 2013;36(5):536–41. doi:10.1007/s12272-013-0066-x
   PubMed Web of Science ®Google Scholar
• Zhang Q-H, Hu Q-X, Xie D, Chang B, Miao H-G, Wang Y-G, Liu D-Z, Li X-D. Ganoderma lucidum exerts an anticancer effect on human osteosarcoma cells via suppressing the Wnt/β-catenin signaling pathway. Integr Cancer Ther. 2019;18:1534735419890917. doi:10.1177/1534735419890917
   Web of Science ®Google Scholar
• Qu L, Li S, Zhuo Y, Chen J, Qin X, Guo G. Anticancer effect of triterpenes from Ganoderma lucidum in human prostate cancer cells. Oncol Lett. 2017;14(6):7467–72. doi:10.3892/ol.2017.7153
   PubMed Web of Science ®Google Scholar
• Barbieri A, Quagliariello V, Del Vecchio V, Falco M, Luciano A, Amruthraj N, Nasti G, Ottaiano A, Berretta M, Iaffaioli R, et al. Anticancer and anti-inflammatory properties of ganoderma lucidum extract effects on melanoma and triple-negative breast cancer treatment. Nutrients. 2017;9(3):210. doi:10.3390/nu9030210
   PubMed Web of Science ®Google Scholar
• Yang Y, Zhang H, Zuo J, Gong X, Yi F, Zhu W, Li L. Advances in research on the active constituents and physiological effects of Ganoderma lucidum. Biomed Dermatol. 2019;3(1):1–17. doi:10.1186/s41702-019-0044-0
   Google Scholar
• Wang Y-Y, Khoo K-H, Chen S-T, Lin C-C, Wong C-H, Lin C-H. Studies on the immuno-modulating and antitumor activities of Ganoderma lucidum (Reishi) polysaccharides: functional and proteomic analyses of a fucose-containing glycoprotein fraction responsible for the activities. Bioorg Med Chem. 2002;10(4):1057–62. doi:10.1016/s0968-0896(01)00377-7
   PubMed Web of Science ®Google Scholar
• Xu F, Li X, Xiao X, Liu L-F, Zhang L, Lin P-P, Zhang S-L, Li Q-S. Effects of Ganoderma lucidum polysaccharides against doxorubicin-induced cardiotoxicity. Biomed Pharmacother. 2017;95:504–12. doi:10.1016/j.biopha.2017.08.118
   PubMed Web of Science ®Google Scholar
• Sun XZ, Liao Y, Li W, Guo LM. Neuroprotective effects of ganoderma lucidum polysaccharides against oxidative stress-induced neuronal apoptosis. Neural Regen Res. 2017;12(6):953–8. doi:10.4103/1673-5374.208590
   PubMed Web of Science ®Google Scholar
• Xu X, Zhang Y, Qu D, Jiang T, Li S. Osthole induces G2/M arrest and apoptosis in lung cancer A549 cells by modulating PI3K/Akt pathway. J Exp Clin Cancer Res. 2011;30:33. doi:10.1186/1756-9966-30-33
   PubMed Web of Science ®Google Scholar
• Moon EJ, Giaccia A. Dual roles of NRF2 in tumor prevention and progression: possible implications in cancer treatment. Free Radic Biol Med. 2015;79:292–9. doi:10.1016/j.freeradbiomed.2014.11.009
   PubMed Web of Science ®Google Scholar
• Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646–74. doi:10.1016/j.cell.2011.02.013
   PubMed Web of Science ®Google Scholar
• Raj L, Ide T, Gurkar AU, Foley M, Schenone M, Li X, Tolliday NJ, Golub TR, Carr SA, Shamji AF, et al. Selective killing of cancer cells by a small molecule targeting the stress response to ROS. Nature. 2011;475(7355):231–4. doi:10.1038/nature10167
   PubMed Web of Science ®Google Scholar
• Patel K, Chowdhury N, Doddapaneni R, Boakye CHA, Godugu C, Singh M. Piperlongumine for enhancing oral bioavailability and cytotoxicity of docetaxel in triple-negative breast cancer. J Pharm Sci. 2015;104(12):4417–26. doi:10.1002/jps.24637
   PubMed Web of Science ®Google Scholar
• Kang Q, Yan S. Piperlongumine reverses doxorubicin resistance through the PI3K/Akt signaling pathway in K562/A02 human leukemia cells. Exp Ther Med. 2015;9(4):1345–50. doi:10.3892/etm.2015.2254
   PubMed Web of Science ®Google Scholar
• Rawat L, Hegde H, Hoti SL, Nayak V. Piperlongumine induces ROS mediated cell death and synergizes paclitaxel in human intestinal cancer cells. Biomed Pharmacother. 2020;128:110243. doi:10.1016/j.biopha.2020.110243
   PubMed Web of Science ®Google Scholar
• Lee J, Cho JY, Kim WK. Anti-inflammation effect of Exercise and Korean red ginseng in aging model rats with diet-induced atherosclerosis. Nutr Res Pract. 2014;8(3):284–91. doi:10.4162/nrp.2014.8.3.284
   PubMed Web of Science ®Google Scholar
• Nguyen CT, Luong TT, Kim GL, Pyo S, Rhee DK. Korean Red Ginseng inhibits apoptosis in neuroblastoma cells via estrogen receptor β-mediated phosphatidylinositol-3 kinase/Akt signaling. J Ginseng Res. 2015;39(1):69–75. doi:10.1016/j.jgr.2014.06.005
   PubMed Web of Science ®Google Scholar
• Hermisson M, Klumpp A, Wick W, Wischhusen J, Nagel G, Roos W, Kaina B, Weller M. O6‐methylguanine DNA methyltransferase and p53 status predict temozolomide sensitivity in human malignant glioma cells. J Neurochem. 2006;96(3):766–76. doi:10.1111/j.1471-4159.2005.03583.x
   PubMed Web of Science ®Google Scholar
• Duan X, He C, Kron SJ, Lin W. Nanoparticle formulations of cisplatin for cancer therapy. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2016;8(5):776–91. doi:10.1002/wnan.1390
   PubMed Web of Science ®Google Scholar
• Klingbeil MFG, Xavier FCA, Sardinha LR, Severino P, Mathor MB, Rodrigues RV, Pinto DS. Cytotoxic effects of mistletoe (Viscum album L.) in head and neck squamous cell carcinoma cell lines. Oncol Rep. 2013;30(5):2316–22. doi:10.3892/or.2013.2732
   PubMed Web of Science ®Google Scholar
• Büssing A, Suzart K, Bergmann J, Pfüller U, Schietzel M, Schweizer K. Induction of apoptosis in human lymphocytes treated with Viscum album L. is mediated by the mistletoe lectins. Cancer Lett. 1996;99(1):59–72. doi:10.1016/0304-3835(95)04038-2
   PubMed Web of Science ®Google Scholar
• Bussing A, Vervecken W, Wagner M, Wagner B, Pfuller U, Schietzel M. Expression of mitochondrial Apo2.7 molecules and caspase-3 activation in human lymphocytes treated with the ribosome-inhibiting mistletoe lectins and the cell membrane permeabilizing viscotoxins. Cytometry. 1999;37(2):133–9. doi:10.1002/(SICI)1097-0320(19991001)37:2<133::AID-CYTO6>3.0.CO;2-A
   PubMedGoogle Scholar
• Wei J, Liu M, Liu H, Wang H, Wang F, Zhang Y, Han L, Lin X. Oleanolic acid arrests cell cycle and induces apoptosis via ROS-mediated mitochondrial depolarization and lysosomal membrane permeabilization in human pancreatic cancer cells. J Appl Toxicol. 2013;33(8):756–65. doi:10.1002/jat.2725
   PubMed Web of Science ®Google Scholar
• Zhou R, Zhang Z, Zhao L, Jia C, Xu S, Mai Q, Lu M, Huang M, Wang L, Wang X, et al. Inhibition of mTOR signaling by oleanolic acid contributes to its anti-tumor activity in osteosarcoma cells. J Orthop Res. 2011;29(6):846–52. doi:10.1002/jor.21311
   PubMed Web of Science ®Google Scholar
• Fulda S, Debatin KM. Betulinic acid induces apoptosis through a direct effect on mitochondria in neuroectodermal tumors. Med Pediatr Oncol. 2000;35(6):616–8. doi:10.1002/1096-911x(20001201)35:6 < 616::aid-mpo27 > 3.0.co;2-n
   PubMedGoogle Scholar
• Nan M-L, Wang X, Li H-J, Yu D-H, Sun W-Y, Xu H-M, He Y-F, Zhao Q-C. Rotundic acid induces Cas3-MCF-7 cell apoptosis through the p53 pathway . Oncol Lett. 2019;17(1):630–7. doi:10.3892/ol.2018.9616
   PubMed Web of Science ®Google Scholar
• Adiwidjaja J, McLachlan AJ, Boddy AV. Curcumin as a clinically-promising anti-cancer agent: pharmacokinetics and drug interactions. Expert Opin Drug Metab Toxicol. 2017;13(9):953–72. doi:10.1080/17425255.2017.1360279
   PubMed Web of Science ®Google Scholar
• Ni J, Tian F, Dahmani FZ, Yang H, Yue D, He S, Zhou J, Yao J. Curcumin-carboxymethyl chitosan (CNC) conjugate and CNC/LHR mixed polymeric micelles as new approaches to improve the oral absorption of P-gp substrate drugs. Drug Deliv. 2016;23(9):3424–35. doi:10.1080/10717544.2016.1189625
   PubMed Web of Science ®Google Scholar
• Mohanty C, Das M, Sahoo SK. Emerging role of nanocarriers to increase the solubility and bioavailability of curcumin. Expert Opin Drug Deliv. 2012;9(11):1347–64. doi:10.1517/17425247.2012.724676
   PubMed Web of Science ®Google Scholar
• Abbaszadeh Z, Çeşmeli S, Biray Avcı Ç. Crucial players in glycolysis: cancer progress. Gene. 2020;726:144158. doi:10.1016/j.gene.2019.144158
   PubMed Web of Science ®Google Scholar
• Dai S, Peng Y, Zhu Y, Xu D, Zhu F, Xu W, Chen Q, Zhu X, Liu T, Hou C, et al. Glycolysis promotes the progression of pancreatic cancer and reduces cancer cell sensitivity to gemcitabine. Biomed Pharmacother. 2020;121:109521. doi:10.1016/j.biopha.2019.109521
   PubMed Web of Science ®Google Scholar
• Yang J, Ren B, Yang G, Wang H, Chen G, You L, Zhang T, Zhao Y. The enhancement of glycolysis regulates pancreatic cancer metastasis. Cell Mol Life Sci. 2020;77(2):305–21. doi:10.1007/s00018-019-03278-z
   PubMed Web of Science ®Google Scholar
• Wu Z, Wu J, Zhao Q, Fu S, Jin J. Emerging roles of aerobic glycolysis in breast cancer. Clin Transl Oncol. 2020;22(5):631–46. doi:10.1007/s12094-019-02187-8
   PubMed Web of Science ®Google Scholar
• Nile SH, Nile AS, Keum YS, Sharma K. Utilization of quercetin and quercetin glycosides from onion (Allium cepa L.) solid waste as an antioxidant, urease and xanthine oxidase inhibitors. Food Chem. 2017;235:119–26. doi:10.1016/j.foodchem.2017.05.043
   PubMed Web of Science ®Google Scholar
• Chen Z, Liu Y, Yang L, Liu P, Zhang Y, Wang X. MiR-149 attenuates endoplasmic reticulum stress-induced inflammation and apoptosis in nonalcoholic fatty liver disease by negatively targeting ATF6 pathway. Immunol Lett. 2020;222:40–8. doi:10.1016/j.imlet.2020.03.003
   PubMed Web of Science ®Google Scholar
• Park W, Park MY, Song G, Lim W. 7-Dimethoxyflavone induces apoptotic cell death in human endometriosis cell lines by activating the endoplasmic reticulum stress pathway. Phytother Res. 2020;34(9):2275–2286. doi:10.1002/ptr.6677
   PubMed Web of Science ®Google Scholar
• Yao X, Tu Y, Xu Y, Guo Y, Yao F, Zhang X. Endoplasmic reticulum stress confers 5-fluorouracil resistance in breast cancer cell via the GRP78/OCT4/lncRNA MIAT/AKT pathway. Am J Cancer Res. 2020;10(3):838–55.
   PubMed Web of Science ®Google Scholar
• Obakan-Yerlikaya P, Arisan ED, Coker-Gurkan A, Palavan-Unsal N. Breast cancer and flavonoids as treatment strategy. In: Pham PV, editor. Breast cancer-from biology to medicine. London: IntechOpen; 2017. p. 305–26.
   Google Scholar
• Zhao Y, He J, Yang L, Luo Q, Liu Z. Histone deacetylase-3 modification of MicroRNA-31 promotes cell proliferation and aerobic glycolysis in breast cancer and is predictive of poor prognosis. J Breast Cancer. 2018;21(2):112–23. doi:10.4048/jbc.2018.21.2.112
   PubMed Web of Science ®Google Scholar
• Biancotto C, Frige G, Minucci S. Histone modification therapy of cancer. Adv Genet. 2010;70:341–86. doi:10.1016/B978-0-12-380866-0.60013-7
   PubMed Web of Science ®Google Scholar
• Min K-J, Kwon TK. Anticancer effects and molecular mechanisms of epigallocatechin-3-gallate. Integr Med Res. 2014;3(1):16–24. doi:10.1016/j.imr.2013.12.001
   PubMedGoogle Scholar
• Zhang Y, Zhao Y, Ran Y, Guo J, Cui H, Liu S. Alantolactone exhibits selective antitumor effects in HELA human cervical cancer cells by inhibiting cell migration and invasion, G2/M cell cycle arrest, mitochondrial mediated apoptosis and targeting Nf-kB signaling pathway. J Buon. 2019;24(6):2310–5.
   PubMed Web of Science ®Google Scholar
• Cui L, Bu W, Song J, Feng L, Xu T, Liu D, Ding W, Wang J, Li C, Ma B, et al. Apoptosis induction by alantolactone in breast cancer MDA-MB-231 cells through reactive oxygen species-mediated mitochondrion-dependent pathway. Arch Pharm Res. 2018;41(3):299–313. doi:10.1007/s12272-017-0990-2
   PubMed Web of Science ®Google Scholar
• Wang Z-F, Liu J, Yang Y-A, Zhu H-L. A review: the anti-inflammatory, anticancer and antibacterial properties of four kinds of licorice flavonoids isolated from licorice. Curr Med Chem. 2020;27(12):1997–2011. doi:10.2174/0929867325666181001104550
   PubMed Web of Science ®Google Scholar
• Boonmuen N, Gong P, Ali Z, Chittiboyina AG, Khan I, Doerge DR, Helferich WG, Carlson KE, Martin T, Piyachaturawat P, et al. Licorice root components in dietary supplements are selective estrogen receptor modulators with a spectrum of estrogenic and anti-estrogenic activities. Steroids. 2016;105:42–9. doi:10.1016/j.steroids.2015.11.006
   PubMed Web of Science ®Google Scholar
• Mandal SK, Debnath U, Kumar A, Thomas S, Mandal SC, Choudhury MD, Palit P. Natural sesquiterpene lactones in the prevention and treatment of inflammatory disorders and cancer: a systematic study of this emerging therapeutic approach based on chemical and pharmacological aspect. LDDD. 2020;17(9):1102–16. doi:10.2174/1570180817999200421144007
   Web of Science ®Google Scholar
• Tayeh Z, Dudai N, Schechter A, Chalifa-Caspi V, Barak S, Ofir R. Molecular Mode of Action of Asteriscus graveolens as an Anticancer Agent. IJMS. 2018;19(8):2162. doi:10.3390/ijms19082162
   Web of Science ®Google Scholar
• Borgert CJ, Borgert SA, Findley KC. Synergism, antagonism, or additivity of dietary supplements: application of theory to case studies. Thromb Res. 2005;117(1–2):123–32. discussion 145–51. doi:10.1016/j.thromres.2005.06.008
   PubMed Web of Science ®Google Scholar
• Cianfruglia L, Minnelli C, Laudadio E, Scirè A, Armeni T. Side effects of curcumin: Epigenetic and antiproliferative implications for normal dermal fibroblast and breast cancer cells. Antioxidants. 2019;8(9):382. doi:10.3390/antiox8090382
   Web of Science ®Google Scholar
• Anand J, Sinha S, Rai N. Highlighting the possible side effects of consuming green tea: a herbal drink. Ecol Environ Conserv 2020;26:S38–S42.
   Google Scholar
• Kothadia JP, Kaminski M, Samant H, Olivera-Martinez M. Hepatotoxicity associated with use of the weight loss supplement Garcinia cambogia: a case report and review of the literature. Case Rep Hepatol. 2018;2018:6483605. doi:10.1155/2018/6483605
   PubMedGoogle Scholar
• Yap KY, See CS, Chan A. Clinically-relevant chemotherapy interactions with complementary and alternative medicines in patients with cancer. Recent Pat Food Nutr Agric. 2010;2(1):12–55. doi:10.2174/2212798411002010012
   PubMedGoogle Scholar
• Hackman GL, Collins M, Lu X, Lodi A, DiGiovanni J, Tiziani S. Predicting and quantifying antagonistic effects of natural compounds given with chemotherapeutic agents: applications for high-throughput screening. Cancers. 2020;12(12):3714. doi:10.3390/cancers12123714
   PubMed Web of Science ®Google Scholar
• Somasundaram S, Edmund NA, Moore DT, Small GW, Shi YY, Orlowski RZ. Dietary curcumin inhibits chemotherapy-induced apoptosis in models of human breast cancer. Cancer Res. 2002;62(13):3868–75.
   PubMed Web of Science ®Google Scholar
• Golden EB, Lam PY, Kardosh A, Gaffney KJ, Cadenas E, Louie SG, Petasis NA, Chen TC, Schönthal AH. Green tea polyphenols block the anticancer effects of bortezomib and other boronic acid-based proteasome inhibitors. Blood. 2009;113(23):5927–37. doi:10.1182/blood-2008-07-171389
   PubMed Web of Science ®Google Scholar
• Rao L, He Z, Meng Q-F, Zhou Z, Bu L-L, Guo S-S, Liu W, Zhao X-Z. Effective cancer targeting and imaging using macrophage membrane-camouflaged upconversion nanoparticles. J Biomed Mater Res A. 2017;105(2):521–30. doi:10.1002/jbm.a.35927
   PubMed Web of Science ®Google Scholar
• Swain S, Sahu PK, Beg S, Babu SM. Nanoparticles for cancer targeting: current and future directions. Curr Drug Deliv. 2016;13(8):1290–302. doi:10.2174/1567201813666160713121122
   PubMed Web of Science ®Google Scholar
• Cocco E, Deng Y, Shapiro EM, Bortolomai I, Lopez S, Lin K, Bellone S, Cui J, Menderes G, Black JD, et al. Dual-targeting nanoparticles for in vivo delivery of suicide genes to chemotherapy-resistant ovarian cancer cells. Mol Cancer Ther. 2017;16(2):323–33. doi:10.1158/1535-7163.MCT-16-0501
   PubMed Web of Science ®Google Scholar
• Dai Y, Xu C, Sun X, Chen X. Nanoparticle design strategies for enhanced anticancer therapy by exploiting the tumour microenvironment. Chem Soc Rev. 2017;46(12):3830–52. doi:10.1039/c6cs00592f
   PubMed Web of Science ®Google Scholar
• Holen I, Speirs V, Morrissey B, Blyth K. In vivo models in breast cancer research: progress, challenges and future directions. Dis Model Mech. 2017;10(4):359–71. doi:10.1242/dmm.028274
   PubMed Web of Science ®Google Scholar
• Wu XM, Wu CF. Network pharmacology: a new approach to unveiling Traditional Chinese Medicine. Chin J Nat Med. 2015;13(1):1–2. doi:10.1016/S1875-5364(15)60001-2
   PubMed Web of Science ®Google Scholar
• Ahmed N, Escalona R, Leung D, Chan E, Kannourakis G. Tumor microenvironment and metabolic plasticity in cancer and cancer stem cells: perspectives on metabolic and immune regulatory signatures in chemoresistant ovarian cancer stem cells. Semin Cancer Biol 2018;53:265–281.
   PubMed Web of Science ®Google Scholar
• Stramucci L, Pranteda A, Bossi G. Insights of crosstalk between p53 protein and the MKK3/MKK6/p38 MAPK signaling pathway in cancer. Cancers. 2018;10(5):131. doi:10.3390/cancers10050131
   PubMed Web of Science ®Google Scholar
• Liu H, Zhang W, Zou B, Wang J, Deng Y, Deng L. DrugCombDB: a comprehensive database of drug combinations toward the discovery of combinatorial therapy. Nucleic Acids Res. 2020;48(D1):D871–D881. doi:10.1093/nar/gkz1007
   PubMed Web of Science ®Google Scholar
• Choudhari AS, Mandave PC, Deshpande M, Ranjekar P, Prakash O. Phytochemicals in cancer treatment: From preclinical studies to clinical practice. Front Pharmacol. 2019;10:1614. doi:10.3389/fphar.2019.01614
   PubMed Web of Science ®Google Scholar
• Lagoa R, Silva J, Rodrigues JR, Bishayee A. Advances in phytochemical delivery systems for improved anticancer activity. Biotechnol Adv. 2020;38:107382. doi:10.1016/j.biotechadv.2019.04.004
   PubMed Web of Science ®Google Scholar